
What can be submitted for reconsideration to the FDA?
Occasionally, applicants may disagree with an FDA decision regarding one of their submissions. AÂ recent guidance published by the U.S. FDA..

Types of ANDA amendments
Recently, the U.S. Food and Drug Administration released a guidance to explain how assessment goals are set for amendments to...
Challenges of building national medical stockpiles
Countries often establish national medical stockpiles to prepare for public health crises and unexpected drug shortages...
How Estonia Became a Startup Hub
Thanks to its push towards digitalizing business services, Estonia has become an attractive hub for entrepreneurs, IT professionals, and ...
Ensuring Drug Safety with Risk Evaluation and Mitigation Strategies (REMS)
One of the pharmaceutical industry’s top priorities is to ensure the safe use of medications without compromising their efficacy...
Estonia: A European hub for scientific research
Estonia is an excellent example of how investment in innovation can drive economic and research growth. On average, 227 PhD degrees are...
Hidden Costs Across the Pharmaceutical Supply Chain
The rising costs of U.S. healthcare affect all participants in the supply chain, from manufacturers to patients...
Two critical factors that affect pharmaceutical supply chains
Comparing bids is a critical step since it affects the overall production cost and product margins. In our experience ...
The Medicare price negotiation: a problem and an opportunity for the generics industry
This autumn, the U.S. Secretary of Health and Human Services (HHS) has finally begun negotiating prices for 10 Medicare Part D drugs as...
Key changes in the generics industry could prevent drug shortages
The growth of the generics market has produced impressive economic benefits for the United States. The Association for Accessible...